Group One Trading’s Alterity Therapeutics ATHE Stock Holding History

Group One Trading’s Portfolio ATHE Stock Details ATHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-330	Closed	-$9K	–	4594
2016 Q1	$9K	Buy	330 +275	+500%	+$9.18K	﹤0.01%	4039
2015 Q4	$2K	Buy	55 +22	+67%	+$1.12K	﹤0.01%	4520
2015 Q3	$2K	Hold	33	–	–	﹤0.01%	4674
2015 Q2	$2K	Buy	33 +11	+50%	+$826	﹤0.01%	4653
2015 Q1	$1K	Sell	22 -235	-91%	-$18.8K	﹤0.01%	4630
2014 Q4	$25K	Sell	257 -345	-57%	-$37.3K	﹤0.01%	3827
2014 Q3	$77K	Sell	602 -466	-44%	-$62.3K	﹤0.01%	3215
2014 Q2	$145K	Sell	1,068 -3,049	-74%	-$348K	﹤0.01%	2663
2014 Q1	$692K	Buy	4,117 +3,780	+1,122%	+$2.09M	0.01%	1384
2013 Q4	$142K	Buy	337 +130	+63%	+$38.9K	﹤0.01%	2732
2013 Q3	$51K	Buy	+207	New	+$47.5K	﹤0.01%	3524

Other funds holding ATHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

OIA

Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Group One Trading's ATHE Position: Q1 2018 in Review

Group One Trading sold out of Alterity Therapeutics (ATHE) in Q1 2018, closing a stake of 4 shares.

Group One Trading first reported a position in ATHE in Q3 2013 and held it in 15 quarters. The position peaked at $207K in Q1 2014. 12 funds tracked by Wall St. Rank hold ATHE as of Q1 2018.

Group One Trading reported no remaining Alterity Therapeutics position as of Q1 2018 after selling out during the quarter.
Group One Trading sold 4 Alterity Therapeutics shares in Q1 2018.
Group One Trading first reported a position in Alterity Therapeutics in Q3 2013 and held it in 15 quarters.
Group One Trading's Alterity Therapeutics position peaked at $207K in Q1 2014.
12 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2018.

Based on Group One Trading's 13F filing for Q1 2018, filed 11 May 2018.